Impact of early abciximab administration on infarct size in patients with ST-elevation myocardial infarction

International Journal of Cardiology

Volumn 155, Issue 2, 2012, Pages 230-235

  Petronio, A Sonia ^a   De Carlo, Marco ^a   Strata, Elisabetta ^b   Gistri, Roberto ^a   Palmieri, Cataldo ^c   Aquaro, Giovanni ^b   Borelli, Gabriele ^a   Vaghetti, Marco ^c   Donne, Mariagrazia Delle ^a   Lombardi, Massimo ^b   Berti, Sergio ^c  

^a UNIVERSITY HOSPITAL OF PISA   (Italy)

^b FONDAZIONE TOSCANA GABRIELE MONASTERIO   (Italy)

^c INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

Angioplasty; Magnetic resonance imaging; Myocardial infarction; Reperfusion

Indexed keywords

ABCIXIMAB; GADOBUTROL;

ADULT; AGED; ARTICLE; BLOOD VESSEL OCCLUSION; CONTINUOUS INFUSION; CONTROLLED STUDY; DELAYED ENHANCEMENT MAGNETIC RESONANCE IMAGING; DISEASE DURATION; DOSAGE SCHEDULE COMPARISON; DRUG EFFICACY; EARLY DIAGNOSIS; EARLY INTERVENTION; ELECTROCARDIOGRAPHY; FEMALE; HEART INFARCTION SIZE; HUMAN; IMAGE ENHANCEMENT; MAJOR CLINICAL STUDY; MALE; MICROANGIOPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TREATMENT RESPONSE;

AGED; ANGIOPLASTY, BALLOON, CORONARY; ANTIBODIES, MONOCLONAL; ANTICOAGULANTS; COMBINED MODALITY THERAPY; DRUG ADMINISTRATION SCHEDULE; ELECTROCARDIOGRAPHY; EMERGENCY MEDICAL SERVICES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TIME FACTORS;

EID: 84857061167     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2010.09.094     Document Type: Article

References (26)

1. J. Godicke, M. Flather, and M. Noc Early versus periprocedural administration of abciximab for primary angioplasty: a pooled analysis of 6 studies Am Heart J 150 2005 1015
2. M. Maioli, F. Bellandi, M. Leoncini, A. Toso, and R.P. Dabizzi Randomized early versus late abciximab in acute myocardial infarction treated with primary coronary intervention (RELAx-AMI Trial) J Am Coll Cardiol 49 2007 1517 1524
3. G. De Luca, C.M. Gibson, and F. Bellandi Early glycoprotein IIb-IIIa inhibitors in primary angioplasty (EGYPT) cooperation: an individual patient data meta-analysis Heart 94 2008 1548 1558
4. S.G. Ellis, M. Tendera, and M.A. de Belder Facilitated PCI in patients with ST-elevation myocardial infarction N Engl J Med 358 2008 2205 2217
5. The TIMI Study Group The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings N Engl J Med 312 1985 932 936
6. A.W. van't Hof, A. Liem, H. Suryapranata, J.C. Hoorntje, M.J. de Boer, and F. Zijlstra Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group Circulation 97 1998 2302 2306
7. M.J. Claeys, J. Bosmans, L. Veenstra, P. Jorens, R. De, and C.J. Vrints Determinants and prognostic implications of persistent ST-segment elevation after primary angioplasty for acute myocardial infarction: importance of microvascular reperfusion injury on clinical outcome Circulation 99 1999 1972 1977
8. V. Positano, A. Pingitore, and A. Giorgetti A fast and effective method to assess myocardial necrosis by means of contrast magnetic resonance imaging J Cardiovasc Magn Reson 7 2005 487 494
9. A.M. Beek, H.P. Kuhl, and O. Bondarenko Delayed contrast-enhanced magnetic resonance imaging for the prediction of regional functional improvement after acute myocardial infarction J Am Coll Cardiol 42 2003 895 901
10. A. Schomig, A. Kastrati, and J. Dirschinger Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. Stent versus Thrombolysis for Occluded Coronary Arteries in Patients with Acute Myocardial Infarction Study Investigators N Engl J Med 343 2000 385 391
11. M. Gick, N. Jander, and H.P. Bestehorn Randomized evaluation of the effects of filter-based distal protection on myocardial perfusion and infarct size after primary percutaneous catheter intervention in myocardial infarction with and without ST-segment elevation Circulation 112 2005 1462 1469
12. F. Bellandi, M. Maioli, M. Leoncini, A. Toso, and R.P. Dabizzi Early abciximab administration in acute myocardial infarction treated with primary coronary intervention Int J Cardiol 108 2006 36 42
13. M. Gyongyosi, H. Domanovits, and W. Benzer Use of abciximab prior to primary angioplasty in STEMI results in early recanalization of the infarct-related artery and improved myocardial tissue reperfusion - results of the Austrian multi-centre randomized ReoPro-BRIDGING Study Eur Heart J 25 2004 2125 2133
14. D.A. Morrow, E.M. Antman, and A. Charlesworth TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an intravenous nPA for treatment of infarcting myocardium early II trial substudy Circulation 102 2000 2031 2037
15. K.C. Wu, E.A. Zerhouni, and R.M. Judd Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction Circulation 97 1998 765 772
16. K.M. Choi, R.J. Kim, G. Gubernikoff, J.D. Vargas, M. Parker, and R.M. Judd Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function Circulation 104 2001 1101 1107
17. J.Y. Hahn, Y.B. Song, and H.C. Gwon Relation of left ventricular infarct transmurality and infarct size after primary percutaneous coronary angioplasty to time from symptom onset to balloon inflation Am J Cardiol 102 2008 1163 1169
18. W.P. Ingkanisorn, K.L. Rhoads, A.H. Aletras, P. Kellman, and A.E. Arai Gadolinium delayed enhancement cardiovascular magnetic resonance correlates with clinical measures of myocardial infarction J Am Coll Cardiol 43 2004 2253 2259
19. T. Baks, R.J. van Geuns, and E. Biagini Effects of primary angioplasty for acute myocardial infarction on early and late infarct size and left ventricular wall characteristics J Am Coll Cardiol 47 2006 40 44
20. G. Sardella, M. Mancone, and C. Bucciarelli-Ducci Thrombus aspiration during primary percutaneous coronary intervention improves myocardial reperfusion and reduces infarct size: the EXPIRA (thrombectomy with export catheter in infarct-related artery during primary percutaneous coronary intervention) prospective, randomized trial J Am Coll Cardiol 53 2009 309 315
21. G. Tarantini, L. Cacciavillani, and F. Corbetti Duration of ischemia is a major determinant of transmurality and severe microvascular obstruction after primary angioplasty: a study performed with contrast-enhanced magnetic resonance J Am Coll Cardiol 46 2005 1229 1235
22. D. Dudek, Z. Siudak, and M. Janzon European registry on patients with ST-elevation myocardial infarction transferred for mechanical reperfusion with a special focus on early administration of abciximab - EUROTRANSFER Registry Am Heart J 156 2008 1147 1154
23. P. Ortolani, A. Marzocchi, and C. Marrozzini Long-term effectiveness of early administration of glycoprotein IIb/IIIa agents to real-world patients undergoing primary percutaneous interventions: results of a registry study in an ST-elevation myocardial infarction network Eur Heart J 30 2009 33 43
24. B.J. Gersh, G.W. Stone, H.D. White, and D.R. Holmes Jr. Pharmacological facilitation of primary percutaneous coronary intervention for acute myocardial infarction: is the slope of the curve the shape of the future? JAMA 293 2005 979 986
25. M. De Carlo, G. Borelli, and R. Gistri Effectiveness of the transradial approach to reduce bleedings in patients undergoing urgent coronary angioplasty with GPIIb/IIIa inhibitors for acute coronary syndromes Catheter Cardiovasc Interv 74 2009 408 415
26. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150